Patents by Inventor Mario DiPaola

Mario DiPaola has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210107015
    Abstract: A rotor system comprises a rotor constructed and arranged to rotate about an axis of rotation. A source of electromagnetic radiation is positioned at a first position of the rotor, the source of electromagnetic radiation configured to emit electromagnetic radiation at one or more wavelengths. The rotor system further includes a sample region. A detector is positioned at a second position of the rotor, the detector constructed and arranged to receive electromagnetic radiation that traverses at least a portion of the sample region.
    Type: Application
    Filed: February 26, 2019
    Publication date: April 15, 2021
    Inventors: Christopher A. Sucato, Mario Dipaola
  • Patent number: 5676942
    Abstract: This invention provides alpha interferon compositions comprising one or a mixture of selected highly antiviral interferon proteins, which compositions are characterized by increased anti-viral activity. These compositions may be used therapeutically in the treatment of viral infection, particularly retroviral or hepatitis infection or as additives to conventional antiviral agents to increase the antiviral potency thereof.
    Type: Grant
    Filed: May 25, 1995
    Date of Patent: October 14, 1997
    Assignee: Interferon Sciences, Inc.
    Inventors: Douglas Testa, Mei-June Liao, Katalin Ferencz-Biro, Abbas Rashidbaigi, Mario DiPaola
  • Patent number: 5503828
    Abstract: This invention provides a novel improved alpha interferon composition characterized by high specific activity, a purity of greater than 95% and which upon use in humans is further characterized by a substantial reduction in side effects normally associated with alpha interferon compositions. Also provided is a method for large scale production of the composition from human peripheral blood leukocytes. This alpha interferon composition may be used therapeutically in the treatment of cancers and diseases of the immune system and/or viral etiology.
    Type: Grant
    Filed: October 5, 1993
    Date of Patent: April 2, 1996
    Assignee: Interferon Sciences, Inc.
    Inventors: Douglas Testa, Mei-June Liao, Katalin Ferencz-Biro, Abbas Rashidbaigi, Mario DiPaola, Manisha Padhye